This site uses cookies to improve your browsing experience. By using this site, you agree to their use. Cookie Information

Efficacy and safety of nintedanib and docetaxel in lung adenocarcinoma patients following treatment with immune checkpoint inhibitors: first interim results of the ongoing non-interventional VARGADO study (NCT02392455)

Grohe